Ovoca Bio PLC (OVB)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
1.00p
Buy
1.30p
-0.125p (-9.80%)
Ovoca Gold PLC gold exploration and mine development company focused on gold and silver deposits in Russia. It also engages in investment activities.
Prices updated at 06 May 2025, 11:10 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
- | - | - | - | - | - | - | - | |
- | - | - | - | - | - | - | - | |
-2m | -1m | -2m | -2m | -2m | -6m | -5m | -2m | |
- | - | - | - | - | - | - | - | |
-959,000 | -381,000 | -2m | -2m | -2m | -5m | -6m | -5m | |
-904,000 | -187,000 | -2m | -2m | -2m | -5m | -5m | -5m | |
Sales, General and administrative | 995,000 | 637,000 | 589,000 | 797,000 | 888,000 | 2m | 2m | 840,000 |
Interest expenses | 11,000 | 9,000 | 10,000 | 23,000 | 16,000 | 21,000 | 39,000 | 5,000 |
Provision for income taxes | - | - | - | - | - | - | - | - |
Operating expenses | 2m | 1m | 2m | 2m | 2m | 6m | 5m | 2m |
Income before taxes | -959,000 | -233,000 | -2m | -2m | -2m | -5m | -6m | -5m |
Net income available to common shareholders | -959,000 | -381,000 | -2m | -2m | -2m | -5m | -6m | -5m |
-0.0118 | -0.0047 | -0.0328 | -0.0192 | -0.0286 | -0.0671 | -0.0688 | -0.0576 | |
Net interest income | 204,000 | -9,000 | -6,000 | -17,000 | -14,000 | -21,000 | -35,000 | -5,000 |
Advertising and promotion | - | - | - | - | - | - | - | - |
Net investment income, net | 391,000 | 925,000 | 316,000 | 428,000 | -103,000 | 634,000 | -1m | 46,000 |
Realised capital gains (losses), net | - | - | - | - | - | - | - | - |
Total benefits, claims and expenses | - | - | - | - | - | - | - | - |
Earnings per share (diluted) | -0.0118 | -0.0047 | -0.0328 | -0.0192 | -0.0286 | -0.0671 | -0.0688 | -0.0576 |
Free cash flow per share | 0.0758 | -0.0176 | -0.0082 | -0.0462 | -0.0355 | -0.0256 | -0.0708 | -0.0178 |
Book value/share | 0.2939 | 0.2422 | 0.1996 | 0.2015 | 0.2183 | 0.1676 | 0.094 | 0.0539 |
Debt equity ratio | - | - | - | - | - | - | - | - |
Balance sheet
Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current assets | 7m | 6m | 3m | 11m | 11m | 7m | 5m | 3m |
Current liabilities | 217,000 | 46,000 | 1m | 427,000 | 486,000 | 1m | 2m | 967,000 |
Total capital | 23m | 22m | 18m | 22m | 19m | 13m | 8m | 3m |
Total debt | - | - | 989,000 | - | - | - | - | - |
Total equity | 23m | 22m | 18m | 22m | 19m | 13m | 8m | 3m |
Total non current liabilities | - | - | - | - | - | - | - | - |
Loans | - | - | - | - | - | - | - | - |
Total assets | 24m | 22m | 22m | 24m | 19m | 15m | 9m | 3m |
Total liabilities | - | - | - | - | - | - | - | - |
Cash and cash equivalents | 7m | 6m | 2m | 10m | 11m | 7m | 4m | 3m |
Common stock | 82m | 82m | 82m | 88m | 82m | 82m | 82m | 82m |
Cash flow
Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 7m | 7m | 6m | 2m | 10m | 11m | 7m | 4m |
Cash dividends paid | - | - | - | - | - | - | - | - |
-395,000 | -1m | -3m | -3m | -3m | -5m | -5m | 1m | |
Investments (gains) losses | -1,000 | 492,000 | -2m | 11m | 8m | -67,000 | 2m | -49,000 |
7m | 6m | 2m | 10m | 11m | 7m | 4m | 3m | |
Net income | - | - | - | - | - | - | - | - |
-394,000 | -1m | -3m | -2m | -2m | -4m | -5m | 1m | |
-1,000 | - | - | -630,000 | -425,000 | -171,000 | -42,000 | -49,000 |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.